The art of histotripsy: a focused ultrasound application that has the potential to treat from head to toe!

Suzanne LeBlang,Timothy J. Ziemlewicz
DOI: https://doi.org/10.1080/02656736.2024.2312608
2024-02-09
International Journal of Hyperthermia
Abstract:Histotripsy is the first noninvasive, nonthermal, nonionizing focused ultrasound treatment modality which could impact many patients as its full potential is realized. The term histotripsy stems from Greek root words 'histo,' meaning soft tissue and 'tripsy,' meaning breakdown, and originally appeared in print from the founding University of Michigan group in 2004 [ Citation 1 ]. Histotripsy falls within the broader group of focused ultrasound therapies, commonly referred to as high-intensity focused ultrasound (HIFU). Before histotripsy, regulatory approvals for a variety of clinical diseases have utilized a form of thermal HIFU ablation to destroy tissue. Histotripsy is differentiated by using short, high-amplitude pulses that lead to mechanical breakdown of tissue. This unique method for a noninvasive therapy confers benefits for nontarget tissue sparing and positive immunologic effects when treating tumors [ Citation 2 , Citation 3 ]. In October 2023, the first FDA approval for histotripsy was granted for the treatment of liver tumors based on data from the #HOPE4LIVER trials (NCT04572633 and NCT04573881) [ Citation 4 ].
oncology,radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?